Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Immune Therapeutics, Inc.

Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
From Immune Therapeutics, Inc.
Via GlobeNewswire
Tickers IMUN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.